title: Cyclic AMP formation in C6 glioma cells: effect of PACAP and VIP in early and late passages.
abstract: Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) exert their actions via common receptors, VPAC1 and VPAC2, which are equally sensitive to both peptides, while PACAP stimulates its specific PAC1-type receptors. Both peptides potently stimulate cAMP production in different biological systems. In the present article, we examined the effects of PACAP and VIP on cAMP formation in C6 rat glioma cells used between passages 12-28 (early) and 120-136 (late). In the presence of the PDE inhibitor IBMX (0.1 mM), PACAP (0.1 microM) and VIP (1 microM) strongly stimulated cAMP synthesis in C6 cells in early passages, but not in C6 cells in late passages. In contrast, forskolin (10 microM), a direct activator of adenylyl cyclase, and isoprenaline (10 microM), a beta-adrenergic receptor agonist, strongly stimulated cAMP production in both early and late C6 cell passages. Concentration-dependent studies carried out in early passages with PACAP-38, PACAP-27, mammalian and chicken VIPs, and PHI/PHM peptides (1-5 microM) revealed that both forms of PACAP produced strong cAMP accumulation, VIP peptides were less effective than PACAP, while the cAMP effects of PHI/PHM peptides were noticeable only at the highest doses tested. These results suggest that C6 glioma cells in early passages possess functional PAC1 and possibly VPAC-type receptors, but either the density of PACAP/VIP receptors progressively declines or the PACAP/VIP receptor-Gs protein coupling becomes less effective through culture passages.
authors.affiliation: Centre for Medical Biology, Polish Academy of Sciences, 106 Lodowa Road, Lodz 93-232, Poland. psokolowska@cbm.pan.pl
authors.forename: Paulina
authors.initials: P
authors.lastname: Sokolowska
authors.forename: Jerzy Z
authors.initials: JZ
authors.lastname: Nowak
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D016922:Cellular Senescence / Q000187:drug effects*; D005576:Colforsin / Q000494:pharmacology; D000242:Cyclic AMP / Q000096:biosynthesis*; D005910:Glioma / Q000378:metabolism*; D007545:Isoproterenol / Q000494:pharmacology; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide / Q000494:pharmacology*; D051381:Rats; D013997:Time Factors; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology*
chemical_list: D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D005576:Colforsin; D014660:Vasoactive Intestinal Peptide; D000242:Cyclic AMP; D007545:Isoproterenol